Skip to content
Home/Companies/Pharma/Celesio

Celesio

Pharma·Germany·Exited 2014·Held 41yr
Entry
1973
Hold
41yr
Exit
2014

Who owns Celesio?

Celesio is a German Pharma company, now owned by McKesson, which acquired it in 2014 from Franz Haniel & Cie.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Franz Haniel & Cie
Investor
Franz Haniel & Cie
Haniel Family Equity · 1991 · Evergreen

Key facts

HQGermany
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
McKesson
Exit Year
2014

More from Haniel Family Equity

Other portfolio companies in the same fund.

ecoworks
ecoworks
Active
ClimateTechGermany· 2023
Sdui
Sdui
Active
SaaSGermany· 2023
1KOMMA5
1komma5
Active
ClimateTechGermany· 2022
Aerones
Aerones
Active
ClimateTechLatvia· 2022
BauWatch
BauWatch
Active
Business ServicesNetherlands· 2021
KMK kinderzimmer
KMK kinderzimmer
Active
EducationGermany· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Celesio?

Celesio is now owned by McKesson, which acquired it in 2014 from Franz Haniel & Cie.

When did McKesson acquire Celesio?

McKesson acquired Celesio in 2014, buying from Franz Haniel & Cie.

Who did Celesio sell to?

Franz Haniel & Cie sold Celesio to McKesson in 2014 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue